Exopharm Limited (ASX:EX1)’s share price dropped 3.5% during mid-day trading on Monday . The company traded as low as A$0.42 ($0.29) and last traded at A$0.42 ($0.29), approximately 16,279 shares changed hands during mid-day trading. The stock had previously closed at A$0.43 ($0.30).
The company has a market capitalization of $33.41 million and a PE ratio of -10.38.
About Exopharm (ASX:EX1)
Exopharm Limited, a biopharmaceutical company, focuses on developing and commercializing clinical human therapeutics in Australia. It is developing Plexaris, an exosome derived from human platelets; and Exomeres, an exosome derived from adult stem cells. The company was founded in 2003 and is headquartered in Melbourne, Australia.
Read More: The Discount Rate – What You Need to Know
Receive News & Ratings for Exopharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exopharm and related companies with MarketBeat.com's FREE daily email newsletter.